Fig. 2From: MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitusOverall survival (OS) of NSCLC patients with diabetes mellitus in different levels of miR-1231 and different treatments. a OS of patients with a high or low level of miR-1231. b OS of patients with different treatments (surgery vs. non-surgery)Back to article page